NCT04880252View on ClinicalTrials.gov

Neuropsychological Indicators of SCD Progression

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
BiomarkersCognitive AssessmentCognitive DeclineNeurocognitive DisordersNeurodegenerative DiseasesSubjective Cognitive Decline
Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT04880252 - Neuropsychological Indicators of SCD Progression | Biotech Hunter | Biotech Hunter